Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>GLI1</i>-Altered neoplasms: From molecular alterations to morphologic and phenotypic features with formal recognition in the upcoming WHO Classification of soft tissue tumors.

Histology and histopathology·2026

Same author

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

Cancer research·2026

Same author

Proposal of a Risk Stratification Algorithm for Extracranial Malignant Rhabdoid Tumors.

Cancer medicine·2026

Same author

circVDJ-seq for T cell clonotype detection in single-cell and spatial multi-omics.

Genome medicine·2026

Same author

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

Bone marrow transplantation·2026

Same author

Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patient.

The oncologist·2026

Search research articles

Related Experiment Video

Updated: May 21, 2026

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

The first European interdisciplinary ewing sarcoma research summit.

Heinrich Kovar¹, Javier Alonso, Pierre Aman

¹Children's Cancer Research Institute, St. Anna Kinderkrebsforschung Vienna, Austria.

Frontiers in Oncology

|June 5, 2012

Summary

European researchers are uniting to improve treatments for pediatric sarcomas, especially Ewing sarcoma (ES). This initiative aims to translate laboratory findings into clinical trials for better patient outcomes.

Keywords:

Ewing sarcoma animal models biomarkers drug screen epigenetics genomics prognosis sarcomagenesis

More Related Videos

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Related Experiment Videos

Last Updated: May 21, 2026

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Area of Science:

Pediatric oncology
Sarcoma research
Cancer biology

Background:

Current chemotherapy for sarcomas, particularly metastatic Ewing sarcoma (ES), has limitations, with survival rates below 20% for ES.
Despite advances in understanding ES biology, clinical application of research findings is hindered by fragmented efforts and lack of a collaborative forum.
The European Network for Cancer Research in Children and Adolescents (ENCCA) aims to bridge this gap.

Purpose of the Study:

To establish biology-based prioritization for innovative targets, drugs, and prognostic markers in pediatric cancers.
To address the urgent need for novel therapeutics in sarcomas, especially metastatic Ewing sarcoma.
To foster collaboration and knowledge exchange among European and North American experts in ES research.

Main Methods:

Convening 30 European expert scientists and 5 North American opinion leaders in December 2011.
Facilitating discussions on the state-of-the-art in Ewing sarcoma research and recent bench results.
Proposing biological studies and novel therapeutics for upcoming European clinical trials (EWING2008 and EWING2012).

Main Results:

A collaborative platform was established to address the fragmentation in Ewing sarcoma research.
Discussions focused on translating laboratory discoveries into clinical practice for pediatric sarcomas.
Strategies for prioritizing and validating new therapeutic approaches were initiated.

Conclusions:

ENCCA serves as a crucial interaction platform for pediatric cancer research and care stakeholders.
The initiative aims to accelerate the clinical translation of promising Ewing sarcoma research.
Enhanced collaboration is essential for developing improved treatment options for children with sarcomas.